{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_Display\ Name in Display Name (approximate match)
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
PRLR-SLICK Cattle by Recombinetics, Inc.
(2022)
Source URL:
First approved in 2022
Source:
PRLR-SLICK Cattle by Recombinetics, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
YorkaPig-HF-RBM20 Swine by Recombinetics, Inc.
(2020)
Source URL:
First approved in 2020
Source:
YorkaPig-HF-RBM20 Swine by Recombinetics, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125408
(2016)
Source URL:
First approved in 2016
Source:
BLA125408
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA103914
(2013)
Source URL:
First approved in 2013
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
CONCEPT
Status:
Investigational
Source:
NCT04296383: Not Applicable Interventional Unknown status Mycoplasma Pneumoniae Pneumonia
(2020)
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Investigational
Source:
NCT02061358: Phase 1 Interventional Completed Viral Infection
(2014)
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
The immunosugar N-9-methoxynonyldeoxynojirimycin (SP-187, UV-4B) is an inhibitor of both glucosidases I and II. In preclinical studies, it displayed inhibition of dengue and influenza virus infection. The compound developed by Emergent BioSolutions and evaluated in phase 1 clinical trials on healthy subjects.
